Koc, Hasan
Hoser, Hasan
Akdag, Yalcin
Kendir, Cemaliye
Ersoy, F. Fevzi http://orcid.org/0000-0001-9722-1560
Article History
Received: 25 May 2018
Accepted: 14 May 2019
First Online: 3 June 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This study was sponsored by AbbVie. AbbVie contributed to the study design, research, and interpretation of data, writing, reviewing, and approving the publication. The design, study conduct, and financial support for the Zemplar PMOS study (protocol number P12-314) were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication. All authors received payments from AbbVie to participate in this study. In addition, F. Fevzi Ersoy has received speaker and/or consultancy fees from AbbVie, Sanofi, Abdi Ibrahim and Roche. Hasan Hoser, Hasan Koc, Yalcin Akdag and Cemaliye Kendir have not received speaker and/or consultancy fees from AbbVie or any other pharmaceutical companies. The authors would like to acknowledge the other participants of the P12-314 Study Team.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.